Q02445 AF NFT

Tissue factor pathway inhibitor

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifbuikzvm6nuoyjgjdphv4lyarr7aihikf2edowxlxu2ujfrhbe2i/metadata.json
IPFS of structure file: 
bafybeiacq7hnar5ul2bu2lu53mqdche24rz37mk4o4glsu6bx3hngjajcu/AF-Q02445-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
First NFT owner address (bech32): 
genesis1gmhu57ydqw37s7w6ekuk254t3w78ug9ndfc7sx
Current NFT ID #461802 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
461802
Accession (UniProt):
Q02445
Name::
Tissue factor pathway inhibitor
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q02445 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q02445|TFPI1_RAT Tissue factor pathway inhibitor OS=Rattus norvegicus OX=10116 GN=Tfpi PE=2 SV=1 MTNKLKKDHAFWAAVCLLLSIVPELLNALPEEDDDTINTDSELRPMKPLHTFCAMKAEDGPCKAMIRSYYFNMNSHQCEEFIYGGCRGNKNRFDTLEECRKTCIPGYKKTTIKTTSGAEKPDFCFLEEDPGICRGFMTRYFYNNQSKQCEQFKYGGCLGNSNNFETLEECRNTCEDPVNEVQKGDYVTNQITVTDRTTVNNVVIPQATKAPSQWDYDGPSWCLEPADSGLCKASEKRFYYNPAIGKCRQFNYTGCGGNNNNFTTKQDCNRACKKDSSKKSSKRAKTQRRRKSFVKVMYENIH